Literature DB >> 28728172

Blur Adaptation to Central Retinal Disease.

Fuensanta A Vera-Diaz1, Russell L Woods2, Eli Peli1.   

Abstract

Purpose: The long-term, low-resolution vision experienced by individuals affected by retinal disease that causes central vision loss (CVL) may change their perception of blur through adaptation. This study used a short-term adaptation paradigm to evaluate adaptation to blur and sharpness in patients with CVL.
Methods: A variation of Webster's procedure was used to measure the point of subjective neutrality (PSN). The image that appeared normal after adaptation to each of seven blur and sharpness levels (PSN) was measured in 12 patients with CVL (20/60 to 20/320) and 5 subjects with normal sight (NS). Patients with CVL used a preferred retinal locus to view the images. Small control studies investigated the effects of long-term and medium-term (1 hour) defocus and diffusive blur.
Results: Adaptation was reliably measured in patients with CVL and in the peripheral vision of NS subjects. The shape of adaptation curves was similar in patients with CVL and both central and peripheral vision of NS subjects. No statistical correlations were found between adaptation and age, visual acuity, retinal eccentricity, or contrast sensitivity. Long-term blur experience by a non-CVL myopic participant caused a shift in the adaptation function. Conversely, medium-term adaptation did not cause a shift in the adaptation function. Conclusions: Blur and sharp short-term adaptation occurred in peripheral vision of normal and diseased retinas. In most patients with CVL, neither adaptation nor blur perception was affected by long-term attention to peripheral low-resolution vision. The impact of blur/sharp adaptation on the benefit of image enhancement techniques for patients with CVL is discussed.

Entities:  

Mesh:

Year:  2017        PMID: 28728172      PMCID: PMC5520677          DOI: 10.1167/iovs.16-20849

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

1.  Neural adjustments to image blur.

Authors:  Michael A Webster; Mark A Georgeson; Shernaaz M Webster
Journal:  Nat Neurosci       Date:  2002-09       Impact factor: 24.884

Review 2.  Effectiveness of interventions influencing activities of daily living in visually impaired patients: a systematic review.

Authors:  Else Poot; Patriek Mistiaen; Sophie Hickox; Cordula Wagner
Journal:  Insight       Date:  2003 Oct-Dec       Impact factor: 0.878

3.  Blur adaptation and myopia.

Authors:  Sini George; Mark Rosenfield
Journal:  Optom Vis Sci       Date:  2004-07       Impact factor: 1.973

4.  Blur adaptation in myopes.

Authors:  Mark Rosenfield; Susan E Hong; Sini George
Journal:  Optom Vis Sci       Date:  2004-09       Impact factor: 1.973

5.  Aging and blur adaptation.

Authors:  Sarah L Elliott; Joseph L Hardy; Michael A Webster; John S Werner
Journal:  J Vis       Date:  2007-04-18       Impact factor: 2.240

6.  Decreased uncorrected vision after a period of distance fixation with spectacle wear.

Authors:  K Pesudovs; N A Brennan
Journal:  Optom Vis Sci       Date:  1993-07       Impact factor: 1.973

7.  Television, computer and portable display device use by people with central vision impairment.

Authors:  Russell L Woods; Premnandhini Satgunam
Journal:  Ophthalmic Physiol Opt       Date:  2011-03-16       Impact factor: 3.117

8.  Reading with a macular scotoma. II. Retinal locus for scanning text.

Authors:  G T Timberlake; E Peli; E A Essock; R A Augliere
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-08       Impact factor: 4.799

9.  Measuring perceived video quality of MPEG enhancement by people with impaired vision.

Authors:  Matthew Fullerton; Russell L Woods; Fuensanta A Vera-Diaz; Eli Peli
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-12       Impact factor: 2.129

10.  Adaptation to interocular differences in blur.

Authors:  Elysse Kompaniez; Lucie Sawides; Susana Marcos; Michael A Webster
Journal:  J Vis       Date:  2013-05-31       Impact factor: 2.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.